565 Phase I combination study of oral vinorelbine (VRL) and oral cyclophosphamide (CTX) in patients with metastatic breast cancer (MBC)

A.J. ten Tije; C. Seynaeve; J.H. Schornagel; J.C. Pouget; B. Laffranchi; G. Blanchot; J. Lieverst; J. ter Steg; J. Verweij; J.H.M. Schellens

doi:10.1016/s1359-6349(03)90597-0

565 Phase I combination study of oral vinorelbine (VRL) and oral cyclophosphamide (CTX) in patients with metastatic breast cancer (MBC)

A.J. ten Tije
, C. Seynaeve
, J.H. Schornagel
, J.C. Pouget
, B. Laffranchi
, G. Blanchot
, J. Lieverst
, J. ter Steg
, J. Verweij
, J.H.M. Schellens

Research output: Contribution to journal › Article › peer-review

Original language	Dutch
Pages (from-to)	S171
Journal	European Journal of Cancer Supplements
Volume	1
Issue number	5
DOIs	https://doi.org/10.1016/s1359-6349(03)90597-0
Publication status	Published - Sept 2003

Access to Document

10.1016/s1359-6349(03)90597-0

Cite this

ten Tije, A. J., Seynaeve, C., Schornagel, J. H., Pouget, J. C., Laffranchi, B., Blanchot, G., Lieverst, J., ter Steg, J., Verweij, J., & Schellens, J. H. M. (2003). 565 Phase I combination study of oral vinorelbine (VRL) and oral cyclophosphamide (CTX) in patients with metastatic breast cancer (MBC). European Journal of Cancer Supplements, 1(5), S171. https://doi.org/10.1016/s1359-6349(03)90597-0

@article{9a323d0de448401fa3bccad305870c5a,

title = "565 Phase I combination study of oral vinorelbine (VRL) and oral cyclophosphamide (CTX) in patients with metastatic breast cancer (MBC)",

author = "\{ten Tije\}, A.J. and C. Seynaeve and J.H. Schornagel and J.C. Pouget and B. Laffranchi and G. Blanchot and J. Lieverst and \{ter Steg\}, J. and J. Verweij and J.H.M. Schellens",

year = "2003",

month = sep,

doi = "10.1016/s1359-6349(03)90597-0",

language = "Nederlands",

volume = "1",

pages = "S171",

journal = "European Journal of Cancer Supplements",

number = "5",

}

ten Tije, AJ, Seynaeve, C, Schornagel, JH, Pouget, JC, Laffranchi, B, Blanchot, G, Lieverst, J, ter Steg, J, Verweij, J & Schellens, JHM 2003, '565 Phase I combination study of oral vinorelbine (VRL) and oral cyclophosphamide (CTX) in patients with metastatic breast cancer (MBC)', European Journal of Cancer Supplements, vol. 1, no. 5, pp. S171. https://doi.org/10.1016/s1359-6349(03)90597-0

TY - JOUR

T1 - 565 Phase I combination study of oral vinorelbine (VRL) and oral cyclophosphamide (CTX) in patients with metastatic breast cancer (MBC)

AU - ten Tije, A.J.

AU - Seynaeve, C.

AU - Schornagel, J.H.

AU - Pouget, J.C.

AU - Laffranchi, B.

AU - Blanchot, G.

AU - Lieverst, J.

AU - ter Steg, J.

AU - Verweij, J.

AU - Schellens, J.H.M.

PY - 2003/9

Y1 - 2003/9

UR - https://www.mendeley.com/catalogue/5fce3fa5-d375-3e86-8a40-78f654673e82/

U2 - 10.1016/s1359-6349(03)90597-0

DO - 10.1016/s1359-6349(03)90597-0

M3 - Artikel

VL - 1

SP - S171

JO - European Journal of Cancer Supplements

JF - European Journal of Cancer Supplements

IS - 5

ER -